Cancer Vaccine Market Size, Share & Trends Report

Cancer Vaccine Market Size, Share & Trends Analysis Report By Indication Type (Bladder, Cervical), By Vaccine Type (Preventive, Therapeutic), By Technology Type (Recombinant, Whole-cell), By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68040-096-2
Number of Pages: 130
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Cancer Vaccine Type Outlook (Revenue, USD Million, 2018 - 2030)
- Preventive Cancer Vaccines
- Therapeutic Cancer Vaccines
- Others
Cancer Vaccine Indication Type Outlook (Revenue, USD Million, 2018 - 2030)
- Prostate Cancer
- Bladder Cancer
- Melanoma
- Cervical Cancer
- Others
Cancer Vaccine Technology Type Outlook (Revenue, USD Million, 2018 - 2030)
- Recombinant Cancer Vaccines
- Whole-cell Cancer Vaccines
- Viral Vector and DNA Cancer Vaccines
- Other Technologies
Cancer Vaccine Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Cancer Vaccine Market, By Vaccine Type
    - Preventive Cancer Vaccines
    - Therapeutic Cancer Vaccines
    - Others
  - North America Cancer Vaccine Market, By Indication Type
    - Prostate Cancer
    - Bladder Cancer
    - Melanoma
    - Cervical Cancer
    - Others
  - North America Cancer Vaccine Market, By Technology Type
    - Recombinant Cancer Vaccines
    - Whole-cell Cancer Vaccines
    - Viral Vector and DNA Cancer Vaccines
    - Other Technologies
  - U.S.
    - U.S. Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - U.S. Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - U.S. Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - Canada
    - Canada Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - Canada Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - Canada Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
- Europe
  - Europe Cancer Vaccine Market, By Vaccine Type
    - Preventive Cancer Vaccines
    - Therapeutic Cancer Vaccines
    - Others
  - Europe Cancer Vaccine Market, By Indication Type
    - Prostate Cancer
    - Bladder Cancer
    - Melanoma
    - Cervical Cancer
    - Others
  - Europe Cancer Vaccine Market, By Technology Type
    - Recombinant Cancer Vaccines
    - Whole-cell Cancer Vaccines
    - Viral Vector and DNA Cancer Vaccines
    - Other Technologies
  - UK
    - UK Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - UK Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - UK Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - Germany
    - Germany Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - Germany Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - Germany Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - France
    - France Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - France Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - France Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - Spain
    - Spain Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - Spain Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - Spain Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - Italy
    - Italy Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - Italy Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - Italy Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - Denmark
    - Denmark Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - Denmark Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - Denmark Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - Sweden
    - Sweden Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - Sweden Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - Sweden Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - Norway
    - Norway Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - Norway Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - Norway Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
- Asia Pacific
  - Asia Pacific Cancer Vaccine Market, By Vaccine Type
    - Preventive Cancer Vaccines
    - Therapeutic Cancer Vaccines
    - Others
  - Asia Pacific Cancer Vaccine Market, By Indication Type
    - Prostate Cancer
    - Bladder Cancer
    - Melanoma
    - Cervical Cancer
    - Others
  - Asia Pacific Cancer Vaccine Market, By Technology Type
    - Recombinant Cancer Vaccines
    - Whole-cell Cancer Vaccines
    - Viral Vector and DNA Cancer Vaccines
    - Other Technologies
  - Japan
    - Japan Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - Japan Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - Japan Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - China
    - China Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - China Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - China Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - India
    - India Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - India Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - India Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - South Korea
    - South Korea Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - South Korea Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - South Korea Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - Australia
    - Australia Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - Australia Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - Australia Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - Thailand
    - Thailand Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - Thailand Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - Thailand Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
- Latin America
  - Latin America Cancer Vaccine Market, By Vaccine Type
    - Preventive Cancer Vaccines
    - Therapeutic Cancer Vaccines
    - Others
  - Latin America Cancer Vaccine Market, By Indication Type
    - Prostate Cancer
    - Bladder Cancer
    - Melanoma
    - Cervical Cancer
    - Others
  - Latin America Cancer Vaccine Market, By Technology Type
    - Recombinant Cancer Vaccines
    - Whole-cell Cancer Vaccines
    - Viral Vector and DNA Cancer Vaccines
    - Other Technologies
  - Brazil
    - Brazil Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - Brazil Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - Brazil Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - Mexico
    - Mexico Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - Mexico Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - Mexico Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - Argentina
    - Argentina Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - Argentina Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - Argentina Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
- MEA
  - MEA Cancer Vaccine Market, By Vaccine Type
    - Preventive Cancer Vaccines
    - Therapeutic Cancer Vaccines
    - Others
  - MEA Cancer Vaccine Market, By Indication Type
    - Prostate Cancer
    - Bladder Cancer
    - Melanoma
    - Cervical Cancer
    - Others
  - MEA Cancer Vaccine Market, By Technology Type
    - Recombinant Cancer Vaccines
    - Whole-cell Cancer Vaccines
    - Viral Vector and DNA Cancer Vaccines
    - Other Technologies
  - South Africa
    - South Africa Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - South Africa Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - South Africa Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - Saudi Arabia
    - Saudi Arabia Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - Saudi Arabia Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - Saudi Arabia Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - UAE
    - UAE Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - UAE Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - UAE Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies
  - Kuwait
    - Kuwait Cancer Vaccine Market, By Vaccine Type
      - Preventive Cancer Vaccines
      - Therapeutic Cancer Vaccines
      - Others
    - Kuwait Cancer Vaccine Market, By Indication Type
      - Prostate Cancer
      - Bladder Cancer
      - Melanoma
      - Cervical Cancer
      - Others
    - Kuwait Cancer Vaccine Market, By Technology Type
      - Recombinant Cancer Vaccines
      - Whole-cell Cancer Vaccines
      - Viral Vector and DNA Cancer Vaccines
      - Other Technologies

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.